Skip to main content
Premium Trial:

Request an Annual Quote

MorphoSys Surpasses 2005 Revenue, Profit Guidance as Receipts Surge 52 Percent

NEW YORK, Feb. 3 (GenomeWeb News) - MorphoSys today said that revenue for 2005 increased 52 percent, causing total receipts and profit to surpass earlier projections, according to preliminary financial data.


Total receipts for the 12 months ended Dec. 31, 2005, increased to33.5 million ($40.2 million) from22 million year over year.


Net income surged to €4.7 million from €300,000 last year.


The company had recently forecast that net income would be3.5 million on revenues of31.5 million. But an earlier-than-planned succession of performance-based payments within existing collaborations made shortly before the end of the year helped the company surpass those projections.


MorphoSys said it will publish its audited financial statements on Feb. 24.

The Scan

More Boosters for US

Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes.

From a Pig

A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports.

For Privacy's Sake

Wired reports that more US states are passing genetic privacy laws.

Science Paper on How Poaching Drove Evolution in African Elephants

In Science this week: poaching has led to the rapid evolution of tuskless African elephants.